Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$100,000.00

Wearable micro-electronics for clinically applied vascularized composite tissue transplantation and reconstructive transplant research

FY 2019-20

Summary
Extremity transplantation has the potential to restore function to a patient's injured limb, but graft rejection and the risks of immunosuppression limit its applicability to all patients in need. The clinical and scientific rationale of the approach is that repetitive protocol biopsies of the skin of vascularized composite allotransplanted (VCA) grafts (e.g., arms and face) are designed to survey for impending failure due to subacute rejection, in which the immune system is activated against the transplanted VCA graft but the patient is without clinical signs of rejection. Despite the potential treatment benefits of protocol biopsies, these procedures lead to scaring and fibrosis, introduce a route for opportunistic infections and oftentimes lead to graft pain. The objective of this project is to develop a wearable device that non-invasively monitors for potential graft rejection and to acquire pre-clinical data to adapt the sensing technology to organ and tissue transplantation. The device is a thin, wearable sensor that records alterations in microvascular blood flow within the skin to provide continuous monitoring of the transplanted graft. This application ultimately targets patients injured by devastating trauma who may undergo VCA; however, the sensor technology developed here has a wider capacity to help and impact a broader patient base. Vascularized composite tissue reconstruction in patients undergoing skin graft surgery after burns or composite tissue flap reconstructive surgery after mastectomy for breast cancer, together represent ~62,000 hospitalized patients annually.
Program
CIHR Fellowship
Location
Illinois, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
412881
Name
Koss Kyle M
Region
Illinois
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Wearable micro-electronics for clinically applied vascularized composite tissue transplantation and reconstructive transplant research
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bioelectronics; Biosensors; Graft Rejection; Immune Response; Nanotechnology; Transplantation
Abstract
Extremity transplantation has the potential to restore function to a patient's injured limb, but graft rejection and the risks of immunosuppression limit its applicability to all patients in need. The clinical and scientific rationale of the approach is that repetitive protocol biopsies of the skin of vascularized composite allotransplanted (VCA) grafts (e.g., arms and face) are designed to survey for impending failure due to subacute rejection, in which the immune system is activated against the transplanted VCA graft but the patient is without clinical signs of rejection. Despite the potential treatment benefits of protocol biopsies, these procedures lead to scaring and fibrosis, introduce a route for opportunistic infections and oftentimes lead to graft pain. The objective of this project is to develop a wearable device that non-invasively monitors for potential graft rejection and to acquire pre-clinical data to adapt the sensing technology to organ and tissue transplantation. The device is a thin, wearable sensor that records alterations in microvascular blood flow within the skin to provide continuous monitoring of the transplanted graft. This application ultimately targets patients injured by devastating trauma who may undergo VCA; however, the sensor technology developed here has a wider capacity to help and impact a broader patient base. Vascularized composite tissue reconstruction in patients undergoing skin graft surgery after burns or composite tissue flap reconstructive surgery after mastectomy for breast cancer, together represent ~62,000 hospitalized patients annually.
Competitiondate
201910
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Koss, Kyle M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~
Direct Payment - $100,000 Grant (2019-20) | Canada Spends